- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03871985
Efficacy of Two Intermittent Subglottic Secretion
March 11, 2019 updated by: The First Hospital of Jilin University
Efficacy of Intermittent Subglottic Secretion Lavage Combined With Aspiration Preventing Ventilator Associated Pneumonia in Patients With Severe Neurological Disease:A Single-center Randomized Controlled Trial
The purpose of this study is to determine the efficacy of intermittent subglottic secretion lavage combined with aspiration preventing ventilator associated pneumonia in patients with severe neurological disease
Study Overview
Status
Unknown
Conditions
Detailed Description
Ventilator-associated pneumonia (VAP) is a common and serious complication of mechanical ventilation.
Many studies have shown that the accumulation of subglottic secretions above the endotracheal cuff plays an important role in the pathogenesis of VAP.
Subglottic secretion drainage (SSD) has been shown to be associated with a lower incidence of VAP in previous meta-analyses.
Most studies in past reported that in the group of patients in whom endotracheal tube (ETT) was used and subglottic secretion drainage was applied compared to the group without subglottic secretion drainage.Very few studies compared two different methods of SSD,such as subglottic secretion lavage combined with aspiration or pure aspiration.The tubes need frequent cleaning as they often get blocked, especially the draining duct.
This may be the reason why they are not commonly applied.
However,subglottic secretion lavage combined with aspiration can reduce the incidence of tube blockage.So
The purpose of this study is to determine the efficacy of intermittent subglottic secretion lavage combined with aspiration preventing ventilator associated pneumonia in patients with severe neurological disease.
Study Type
Interventional
Enrollment (Anticipated)
234
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients aged between 18 and 80 years requiring mechanical ventilation for more than 72 hours with placement of an ETT( equipped with a dorsal suction catheter for subglottic secretion drainage)
Exclusion Criteria:
- Exclusion criteria were patients endotracheal intubation was performed before admission, history of HIV, immunosuppression, leukopenia, patient refusal,and
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Lavage combined with aspiration
Intermittent subglottic secretions lavage combined with aspiration
|
Ventilator-associated pneumonia preventive measures were applied to all patients according to VAP bundle.
Subglottic secretion lavage combined with aspiration was performed every 4 hours: Underwent preoxygenation before cuff pressure checking, and was maintained between 30 and 35 cmH2O.
After aspirating secretions from the mouth, nose, and airway, 2-5 mL distilled sterile water was instilled through the subglottic lumen, and then the negative pressure suction device is connected with the outer opening of the side cavity of endotracheal intubation for suction with a negative pressure of 100 mmHg, and each suction was kept under 15 seconds.
Repeat lavage and aspiration until the irrigation fluid is clear.
After washing, cuff pressure checking and was maintained between 25 and 30 cmH2O.
|
ACTIVE_COMPARATOR: Pure aspiration
Intermittent subglottic secretions aspiration
|
Ventilator-associated pneumonia preventive measures were applied to all patients according to VAP bundle.
Subglottic secretion aspiration was performed every 4 hours:Underwent preoxygenation before cuff pressure checking ,and was maintained between 25 and 30 cmH2O.
After aspirating secretions from the mouth, nose, and airway, the negative pressure suction device is connected with the outer opening of the side cavity of endotracheal intubation for suction with a negative pressure of 100 mmHg, and each suction was kept under 15 seconds.
Repeat suction until the secretion is completely absorbed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of ventilator-associated pneumonia
Time Frame: through study completion, an average of 10 months
|
is pneumonia that occurs when an artificial airway is established and mechanically ventilated
|
through study completion, an average of 10 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of draining duct blockage
Time Frame: through study completion, an average of 10 months
|
If mucus flow stopped during subglottic suctioning with a sudden increase of the negative pressure in the proximal port of the suction suggesting a probable occlusion
|
through study completion, an average of 10 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
length of mechanical ventilation
Time Frame: through study completion, an average of 10 months
|
length of mechanical ventilation
|
through study completion, an average of 10 months
|
The coincidence rate between pathogens of subglottic secretions and the lower respiratory tract
Time Frame: through study completion, an average of 10 months
|
The coincidence rate between pathogens of subglottic secretions and the lower respiratory tract
|
through study completion, an average of 10 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
March 15, 2019
Primary Completion (ANTICIPATED)
December 30, 2019
Study Completion (ANTICIPATED)
January 15, 2020
Study Registration Dates
First Submitted
February 19, 2019
First Submitted That Met QC Criteria
March 11, 2019
First Posted (ACTUAL)
March 12, 2019
Study Record Updates
Last Update Posted (ACTUAL)
March 12, 2019
Last Update Submitted That Met QC Criteria
March 11, 2019
Last Verified
December 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SSD-SSLACA
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventilator Associated Pneumonia
-
Hospital Alemão Oswaldo CruzMinistry of Health, BrazilRecruitingHealthcare-Associated Pneumonia | Ventilator-Associated Pneumonia | Healthcare Associated InfectionBrazil
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Cubist Pharmaceuticals LLCCompletedLung Diseases | Healthcare-Associated Pneumonia | Ventilator-Associated Pneumonia
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
Hospital Universitari Joan XXIII de Tarragona.UnknownPneumonia | Nosocomial Pneumonia | Ventilator-Associated PneumoniaSpain
-
Groupe Hospitalier Paris Saint JosephRecruitingVentilator-associated PneumoniaFrance
-
University of MichiganNational Institutes of Health (NIH); National Center for Advancing Translational...CompletedVAP - Ventilator Associated PneumoniaUnited States
-
Denver Health and Hospital AuthorityCompletedEarly Ventilator Associated PneumoniaUnited States
-
Centre Hospitalier Departemental VendeeMinistry of Health, France; University Hospital, ToursCompletedVentilator-associated PneumoniaBelgium, France
-
Bactiguard ABCompletedVentilator-associated PneumoniaBelgium
Clinical Trials on Subglottic secretion lavage combined with aspiration
-
Dr. John MuscedereActive, not recruitingCeragenin Coated Endotracheal Tubes for the Prevention of Ventilator Associated Pneumonia (CEASEVAP)Ventilator Associated PneumoniaCanada